In lung cancer, tumors with low IRS-1 and high IRS-2 expression were associated with poor outcomes in adenocarcinoma and squamous cell carcinoma, indicating a potential role for IRS-2 in the aggressive behavior of non-small cell lung cancer [25]. The gene discussed is IRS2; the disease is non-small cell lung carcinoma.